Leerink Partners Starts WAVE Life Sciences (WVE) at Outperform
Tweet
Share
E-mailGet Alerts WVE Hot Sheet
Price: $5.31 +2.12%
Rating Summary:
20 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
20 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Leerink Partners initiates coverage on WAVE Life Sciences (NASDAQ: WVE) with a Outperform rating and a price target of $61.00.
For an analyst ratings summary and ratings history on WAVE Life Sciences click here. For more ratings news on WAVE Life Sciences click here.
Shares of WAVE Life Sciences closed at $44.04 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wave Life Sciences Announces Completion of Redomiciliation to Delaware
- Oppenheimer Starts Carriage Services (CSV) at Outperform
- Axis Capital Limited Assumes Jubilant Foodworks Ltd (JUBI:IN) at Reduce (3)
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
